We all agree that we support the aim of supporting low cost for medicines, but is keeping tariffs on products the way to do that?

I would urge Republicans on this Subcommittee to try to help the leadership.

The hearing will come to order. Good afternoon.

Thank you again for your presence here and taking time out of your busy schedule and for your testimony.

This is a priority for us to complete this year. And its timely renewal is critical.

It provides certainty for you?

The Miscellaneous Tariff Bill has always been--not always, but in recent years, has been hallmarked by transparency.

The last MTB expired in 2012, and left American manufacturers without a process.

Reducing these barriers would increase opportunities for the United States companies to compete and win.

If we want to remain competitive, then we must focus on doing more in the Asia-Pacific region.

I am convinced that KORUS, our trade agreement with Korea has been a great success for both the United States and Korea.